CIK 1442273
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 52.02% | 27 |
| Oil, Gas & Consumable Fuels | 22.01% | 3 |
| Health Care Providers & Services | 8.67% | 3 |
| Specialty Retail | 5.40% | 1 |
| Semiconductors & Semiconductor Equipment | 2.61% | 4 |
| Utilities | 2.02% | 1 |
| Metals & Mining | 1.78% | 1 |
| Software | 1.07% | 3 |
| Unclassified | 0.86% | 3 |
| Health Care Equipment & Supplies | 0.82% | 1 |
| Communications Equipment | 0.76% | 2 |
| Electrical Equipment & Components | 0.48% | 1 |
| Banks | 0.45% | 1 |
| Coal & Consumable Fuels | 0.44% | 1 |
| Distributors | 0.40% | 2 |
| Life Sciences Tools & Services | 0.15% | 1 |
| Technology Hardware & Equipment | 0.06% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | KRYS | Krystal Biotech, Inc. | Health Care | 12.28% |
| 2 | CVX | CHEVRON CORP | Energy | 12.20% |
| 3 | XOM | EXXON MOBIL CORP | Energy | 9.33% |
| 4 | CELC | Celcuity Inc. | Health Care | 8.22% |
| 5 | TGTX | TG THERAPEUTICS, INC. | Health Care | 6.50% |
| 6 | ABVX | Abivax S.A. | Health Care | 6.20% |
| 7 | AMZN | AMAZON COM INC | Consumer Discretionary | 5.40% |
| 8 | VKTX | Viking Therapeutics, Inc. | Health Care | 5.35% |
| 9 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Health Care | 4.07% |
| 10 | NKTR | NEKTAR THERAPEUTICS | Health Care | 4.01% |
53/56 names classified · sector 99.1% of weight · industry 99.1% · mkt cap 92.9%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 99.1% of the book is sector-classified (unclassified names shown, never dropped).
Only 38% of book weight classified — the grid is NOT representative of the whole book.
Classified: 38.3% of book weight (15/56 names) · unclassified 61.7%: KRYS, CELC, ABVX, VKTX, ARWR, NKTR, CYTK, ALMS, ET, AAOI +31 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | KRYSKRYSTAL BIOTECH INC | 60,477 | $16M | 12.3% | HOLD |
| 2 | CVXCHEVRON CORP NEW | 75,000 | $16M | 12.2% | TRIM −4% |
| 3 | XOMEXXON MOBIL CORP | 70,000 | $12M | 9.3% | TRIM −15% |
| 4 | CELCCELCUITY INC | 91,675 | $10M | 8.2% | ADD 45% |
| 5 | TGTXTG THERAPEUTICS INC | 249,025 | $8M | 6.5% | TRIM −7% |
| 6 | ABVXABIVAX SA | 70,900 | $8M | 6.2% | ADD 11% |
| 7 | AMZNAMAZON COM INC | 33,000 | $7M | 5.4% | ADD 34% |
| 8 | VKTXVIKING THERAPEUTICS INC | 209,300 | $7M | 5.4% | HOLD |
| 9 | ARWRARROWHEAD PHARMACEUTICALS IN | 82,500 | $5M | 4.1% | ADD 10% |
| 10 | NKTRNEKTAR THERAPEUTICS | 70,900 | $5M | 4.0% | ADD 38% |
| 11 | CYTKCYTOKINETICS INC | 64,500 | $4M | 3.3% | HOLD |
| 12 | ALMSALUMIS INC | 174,250 | $4M | 3.0% | NEW |
| 13 | ETENERGY TRANSFER L P | 133,100 | $3M | 2.0% | HOLD |
| 14 | FCXFREEPORT MCMORAN INC | 38,500 | $2M | 1.8% | NEW |
| 15 | AAOIAPPLIED OPTOELECTRONICS INC | 25,900 | $2M | 1.7% | NEW |
| 16 | XENEXENON PHARMACEUTICALS INC | 33,500 | $2M | 1.5% | NEW |
| 17 | NUVBNUVATION BIO INC | 290,000 | $1M | 1.0% | TRIM −52% |
| 18 | STAASTAAR SURGICAL CO | 55,500 | $1M | 0.8% | HOLD |
| 19 | PRAXPRAXIS PRECISION MEDICINES I | 2,700 | $869,913 | 0.7% | ADD 286% |
| 20 | GBTCGRAYSCALE BITCOIN TRUST ETF | 15,400 | $812,504 | 0.6% | TRIM −55% |
| 21 | SSENTINELONE INC | 54,300 | $699,384 | 0.5% | NEW |
| 22 | LITELUMENTUM HLDGS INC | 900 | $632,484 | 0.5% | NEW |
| 23 | BEBLOOM ENERGY CORP | 4,500 | $609,705 | 0.5% | TRIM −65% |
| 24 | CRGYCRESCENT ENERGY COMPANY | 45,000 | $607,500 | 0.5% | TRIM −27% |
| 25 | KURAKURA ONCOLOGY INC | 73,900 | $600,807 | 0.5% | HOLD |
| 26 | VIRVIR BIOTECHNOLOGY INC | 64,300 | $576,128 | 0.5% | NEW |
| 27 | CRCLCIRCLE INTERNET GROUP INC | 6,000 | $572,460 | 0.4% | NEW |
| 28 | HCCWARRIOR MET COAL INC | 6,000 | $558,900 | 0.4% | TRIM −50% |
| 29 | PATHUIPATH INC | 50,000 | $555,000 | 0.4% | ADD 6% |
| 30 | SRRKSCHOLAR ROCK HLDG CORP | 10,800 | $530,928 | 0.4% | TRIM −10% |
| 31 | WGSGENEDX HOLDINGS CORP | 8,000 | $513,760 | 0.4% | ADD 167% |
| 32 | MUMICRON TECHNOLOGY INC | 1,500 | $506,760 | 0.4% | NEW |
| 33 | NVDANVIDIA CORPORATION | 2,800 | $488,320 | 0.4% | NEW |
| 34 | REPLREPLIMUNE GROUP INC | 61,500 | $470,475 | 0.4% | HOLD |
| 35 | RGNXREGENXBIO INC | 56,000 | $469,280 | 0.4% | TRIM −32% |
| 36 | PALIPALISADE BIO INC | 257,500 | $450,625 | 0.4% | ADD 72% |
| 37 | OLMAOLEMA PHARMACEUTICALS INC | 25,000 | $372,750 | 0.3% | TRIM −53% |
| 38 | GLUEMONTE ROSA THERAPEUTICS INC | 22,500 | $370,125 | 0.3% | NEW |
| 39 | ONDSONDAS INC | 37,500 | $339,000 | 0.3% | NEW |
| 40 | ACOGALPHA COGNITION INC | 51,500 | $282,735 | 0.2% | HOLD |
| 41 | MBXMBX BIOSCIENCES INC | 9,000 | $268,650 | 0.2% | NEW |
| 42 | APCARKO PETE CORP | 15,000 | $268,350 | 0.2% | NEW |
| 43 | KYTXKYVERNA THERAPEUTICS INC | 30,000 | $258,900 | 0.2% | ADD 20% |
| 44 | RYZRYERSON HLDG CORP | 10,800 | $242,784 | 0.2% | NEW |
| 45 | NKLRTERRA INNOVATUM GLOBAL NV | 45,000 | $208,800 | 0.2% | HOLD |
| 46 | INCYINCYTE CORP | 2,000 | $188,240 | 0.1% | NEW |
| 47 | CAPRCAPRICOR THERAPEUTICS INC | 5,000 | $152,000 | 0.1% | ADD 233% |
| 48 | VPGVISHAY PRECISION GROUP INC | 3,000 | $130,260 | 0.1% | NEW |
| 49 | ESPRESPERION THERAPEUTICS INC NE | 47,500 | $130,150 | 0.1% | HOLD |
| 50 | AMLXAMYLYX PHARMACEUTICALS INC | 9,000 | $125,100 | 0.1% | HOLD |
| 51 | LSPDLIGHTSPEED COMMERCE INC | 12,500 | $112,000 | 0.1% | HOLD |
| 52 | CMPSCOMPASS PATHWAYS PLC | 15,500 | $85,715 | 0.1% | NEW |
| 53 | LTRXLANTRONIX INC | 15,000 | $78,600 | 0.1% | NEW |
| 54 | SSYSSTRATASYS LTD | 10,000 | $78,100 | 0.1% | HOLD |
| 55 | HIMSHIMS & HERS HEALTH INC | 2,500 | $51,900 | 0.0% | NEW |
| 56 | PDSBPDS BIOTECHNOLOGY CORP | 30,000 | $18,150 | 0.0% | HOLD |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| KRYSKRYSTAL BIOTECH INC | — | — | — | — | 61K | 60K | $16M |
| CVXCHEVRON CORP NEW | — | — | — | — | 79K | 75K | $16M |
| XOMEXXON MOBIL CORP | — | — | — | — | 83K | 70K | $12M |
| CELCCELCUITY INC | — | — | — | — | 63K | 92K | $10M |
| TGTXTG THERAPEUTICS INC | — | — | — | — | 269K | 249K | $8M |
| ABVXABIVAX SA | — | — | — | — | 64K | 71K | $8M |
| AMZNAMAZON COM INC | — | — | — | — | 25K | 33K | $7M |
| VKTXVIKING THERAPEUTICS INC | — | — | — | — | 206K | 209K | $7M |
| ARWRARROWHEAD PHARMACEUTICALS IN | — | — | — | — | 75K | 83K | $5M |
| NKTRNEKTAR THERAPEUTICS | — | — | — | — | 51K | 71K | $5M |
| CYTKCYTOKINETICS INC | — | — | — | — | 65K | 65K | $4M |
| ALMSALUMIS INC | — | — | — | — | — | 174K | $4M |
| ETENERGY TRANSFER L P | — | — | — | — | 133K | 133K | $3M |
| FCXFREEPORT MCMORAN INC | — | — | — | — | — | 39K | $2M |
| AAOIAPPLIED OPTOELECTRONICS INC | — | — | — | — | — | 26K | $2M |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Where this firm's principals came from and which firms its alumni went on to found.
